<?xml version="1.0" encoding="UTF-8"?>
<metabolite>
  <version>1.0</version>
  <creation_date>2016-09-30 22:36:36 UTC</creation_date>
  <update_date>2020-04-22 15:05:19 UTC</update_date>
  <accession>BMDB0000790</accession>
  <secondary_accessions>
    <accession>BMDB00790</accession>
  </secondary_accessions>
  <name>N-Palmitoylsphingosine</name>
  <description/>
  <synonyms>
    <synonym>D-erythro-C16-Ceramide</synonym>
    <synonym>D-erythro-D4-Ceramide</synonym>
    <synonym>N-Palmitoyl 4-sphingenine</synonym>
    <synonym>N-Palmitoyl-D-sphingosine</synonym>
    <synonym>[R-[R*,s*-(e)]]-N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-hexadecanamide</synonym>
    <synonym>C(16)-Ceramide</synonym>
    <synonym>C16-Ceramide</synonym>
    <synonym>C16-Palmitoylceramide</synonym>
    <synonym>N-Palmitoylsphingosine, (r*,s*-(e))-(+-)</synonym>
    <synonym>N-Palmitoylsphingosine, R-(r*,s*-(e))</synonym>
    <synonym>NFA(C16)cer</synonym>
    <synonym>PCer CPD</synonym>
    <synonym>Palmitoylceramide</synonym>
    <synonym>N-(1,3-Dihydroxyoctadec-4-en-2-yl)hexadecanimidate</synonym>
    <synonym>N-Palmitoylsphingosine</synonym>
    <synonym>C16-0(Palmitoyl)ceramide</synonym>
    <synonym>Ceramide-C16</synonym>
  </synonyms>
  <chemical_formula>C34H67NO3</chemical_formula>
  <average_molecular_weight>537.9007</average_molecular_weight>
  <monisotopic_moleculate_weight>537.512095015</monisotopic_moleculate_weight>
  <iupac_name>N-[(4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide</iupac_name>
  <traditional_iupac>N-[(4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide</traditional_iupac>
  <cas_registry_number/>
  <smiles>CCCCCCCCCCCCCCCC(=O)NC(CO)C(O)\C=C\CCCCCCCCCCCCC</smiles>
  <inchi>InChI=1S/C34H67NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,32-33,36-37H,3-26,28,30-31H2,1-2H3,(H,35,38)/b29-27+</inchi>
  <inchikey>YDNKGFDKKRUKPY-ORIPQNMZSA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as long-chain ceramides. These are ceramides bearing a long chain fatty acid.</description>
    <kingdom>Organic compounds</kingdom>
    <super_class>Lipids and lipid-like molecules</super_class>
    <class>Sphingolipids</class>
    <sub_class>Ceramides</sub_class>
    <direct_parent>Long-chain ceramides</direct_parent>
    <alternative_parents>
      <alternative_parent>Carbonyl compounds</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>N-acyl amines</alternative_parent>
      <alternative_parent>Organic oxides</alternative_parent>
      <alternative_parent>Organonitrogen compounds</alternative_parent>
      <alternative_parent>Organopnictogen compounds</alternative_parent>
      <alternative_parent>Primary alcohols</alternative_parent>
      <alternative_parent>Secondary alcohols</alternative_parent>
      <alternative_parent>Secondary carboxylic acid amides</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>Alcohol</substituent>
      <substituent>Aliphatic acyclic compound</substituent>
      <substituent>Carbonyl group</substituent>
      <substituent>Carboxamide group</substituent>
      <substituent>Carboxylic acid derivative</substituent>
      <substituent>Fatty acyl</substituent>
      <substituent>Fatty amide</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>Long-chain ceramide</substituent>
      <substituent>N-acyl-amine</substituent>
      <substituent>Organic nitrogen compound</substituent>
      <substituent>Organic oxide</substituent>
      <substituent>Organic oxygen compound</substituent>
      <substituent>Organonitrogen compound</substituent>
      <substituent>Organooxygen compound</substituent>
      <substituent>Organopnictogen compound</substituent>
      <substituent>Primary alcohol</substituent>
      <substituent>Secondary alcohol</substituent>
      <substituent>Secondary carboxylic acid amide</substituent>
    </substituents>
    <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
    <external_descriptors>
    </external_descriptors>
  </taxonomy>
  <experimental_properties>
    <state>Solid</state>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>9.49</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>-7.11</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>10.87</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>13.62</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>0.02</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>N-[(4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>537.9007</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>537.512095015</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>CCCCCCCCCCCCCCCC(=O)NC(CO)C(O)\C=C\CCCCCCCCCCCCC</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C34H67NO3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C34H67NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,32-33,36-37H,3-26,28,30-31H2,1-2H3,(H,35,38)/b29-27+</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>YDNKGFDKKRUKPY-ORIPQNMZSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>69.56</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>165.78</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>73.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>30</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <pathways>
  </pathways>
  <spectra>
  </spectra>
  <normal_concentrations>
  </normal_concentrations>
  <foodb_id/>
  <chemspider_id/>
  <pubchem_compound_id>5353456</pubchem_compound_id>
  <kegg_id/>
  <chebi_id/>
  <drugbank_id/>
  <pdbe_id/>
  <meta_cyc_id/>
  <phenol_explorer_compound_id/>
  <knapsack_id/>
  <bigg_id/>
  <wikipedia_id/>
  <metlin_id/>
  <synthesis_reference>Duclos, R. I.  The total syntheses of D-erythro-sphingosine, N-palmitoylsphingosine (ceramide), and glucosylceramide (cerebroside) via an azidosphingosine analog.    Chemistry and Physics of Lipids  (2001),  111(2),  111-138.</synthesis_reference>
  <general_references>
  </general_references>
  <protein_associations>
  </protein_associations>
</metabolite>
